Combination of anthracyclines and anti-CD47 therapy inhibit invasive breast cancer growth while preventing cardiac toxicity by regulation of autophagy.

ABSTRACT:

Background

A perennial challenge in systemic cytotoxic cancer therapy is to eradicate primary tumors and metastatic disease while sparing normal tissue from off-target effects of chemotherapy. Anthracyclines such as doxorubicin are effective chemotherapeutic agents for which dosing is limited by development of cardiotoxicity. Our published evidence shows that targeting CD47 enhances radiation-induced growth delay of tumors while remarkably protecting soft tissues. The protection of cell viability observed with CD47 is mediated autonomously by activation of protective autophagy. However, whether CD47 protects cancer cells from cytotoxic chemotherapy is unknown.

Methods

We tested the effect of CD47 blockade on cancer cell survival using a 2-dimensional high-throughput cell pro

SUBMITTER: Feliz-Mosquea YR 

PROVIDER: S-EPMC6195817 | biostudies-literature | 2018 Nov

REPOSITORIES: biostudies-literature